Cervical Cancers Clinical Trials

14 recruiting

Cervical Cancers Trials at a Glance

15 actively recruiting trials for cervical cancers are listed on ClinicalTrialsFinder across 6 cities in 7 countries. The largest study group is Not Applicable with 7 trials, with the heaviest enrollment activity in Beijing, Shanghai, and Guangzhou. Lead sponsors running cervical cancers studies include Obstetrics & Gynecology Hospital of Fudan University, Evopoint Biosciences Inc., and DL Analytics.

Browse cervical cancers trials by phase

Treatments under study

About Cervical Cancers Clinical Trials

Looking for clinical trials for Cervical Cancers? There are currently 14 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Cervical Cancers trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Cervical Cancers clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 115 of 15 trials

Recruiting
Phase 1Phase 2

Study of XNW28012 in Subjects With Advanced Solid Tumors Who Failed Standard Treatments

Ovarian CancerPancreatic CarcinomaAdvanced Solid Tumors+1 more
Evopoint Biosciences Inc.350 enrolled24 locationsNCT06799637
Recruiting
Not Applicable

Validation of a Lab-free Low-cost Screening Test for Prevention of Cervical Cancer

Uterine Cervical NeoplasmsCervical CancersCervical Intraepithelial Neoplasia+1 more
DL Analytics10,000 enrolled1 locationNCT06815939
Recruiting
Phase 2

Serplulimab With Chemoradiotherapy for Postoperative Cervical Cancer With Risk Factors

Cervical Cancers
Tianjin Medical University Cancer Institute and Hospital134 enrolled1 locationNCT06727617
Recruiting
Not Applicable

The Effects of Immunonutrition Therapy on Locally Advanced Cervical Cancer Patients

Cervical Cancers
SHUANG ZHENG JIA, PhD50 enrolled1 locationNCT06349148
Recruiting
Phase 2

Iparomlimab/Tuvonralimab Injection Plus CCRT in LACC

LOCALLY ADVANCED CERVICAL CANCERS
Cancer Institute and Hospital, Chinese Academy of Medical Sciences30 enrolled1 locationNCT07232654
Recruiting
Not Applicable

Use Misoprostol to Optimize Prevention of Cervical Cancer

Cervical Cancers
University of Alabama at Birmingham420 enrolled1 locationNCT06669533
Recruiting
Phase 2

Ivonescimab Combined With Paclitaxel and Cisplatin as Neoadjuvant Therapy Followed by Type A Hysterectomy in Stage IB2 and IIA1 Cervical Cancer

Cervical Cancers
Obstetrics & Gynecology Hospital of Fudan University20 enrolled1 locationNCT07130240
Recruiting
Not Applicable

Minimally Invasive Pelvic Exenteration in Vaginal or Cervical Cancer Recurrence

Cervical CancersVaginal Cancers
Fondazione Policlinico Universitario Agostino Gemelli IRCCS64 enrolled1 locationNCT06867445
Recruiting
Phase 2

Neoadjuvant Immunochemotherapy for Locally Advanced Cervical Cancer: a Prospective, Single-arm, Phase II Clinical Trial

Cervical Cancers
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University34 enrolled1 locationNCT07003620
Recruiting
Phase 2

Phase II Trial Comparison of 3 vs 4 Fractions (BRACHY-FIT).

Cervical Cancers
Stanford University41 enrolled1 locationNCT07022470
Recruiting

Negative HPV Test Results on Infinity/GeneXpert® With the Presence of a Late Amplification Signal: What Does This Mean ? (PaPCR)

Cervical CancersPapillomavirus InfectionsPapillomavirus Type 16/18 Infection
University Hospital, Brest47 enrolled1 locationNCT06919627
Recruiting
Phase 2

Iparomlimab and Tuvonralimab Combined With Paclitaxel and Cisplatin as Neoadjuvant Therapy for CC

Cervical Cancers
Obstetrics & Gynecology Hospital of Fudan University35 enrolled1 locationNCT06878222
Recruiting
Not Applicable

Unidos Contra el VPH

Cervical CancersHuman Papilloma Virus (HPV)
University of Texas at Austin735 enrolled1 locationNCT06825689
Recruiting
Not Applicable

GYNecologic Cancer-Related COGnitive Impairment

Ovarian CancerEndometrial CancerUterine Cancer+4 more
Northwestern University60 enrolled1 locationNCT06662435
Recruiting
Not Applicable

Nurse-led Primary Healthcare Intervention Model in Women's Health Management in Hong Kong

Breast CancerHypertensionOsteoporosis+5 more
The University of Hong Kong1,728 enrolled3 locationsNCT06628388